Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”
Crossref DOI link: https://doi.org/10.1007/s40744-019-00187-2
Published Online: 2019-12-10
Published Print: 2020-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van Leeuwen, Kevin D. B. http://orcid.org/0000-0002-4526-0426
Bohnen, Arthur M.
Text and Data Mining valid from 2019-12-10
Version of Record valid from 2019-12-10
Article History
Received: 1 November 2019
First Online: 10 December 2019